DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Adenoscan (Adenosine) - Indications and Dosage

 
 



Indications and Usage

Intravenous Adenoscan is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately (See WARNINGS).

Dosage and Administration

For intravenous infusion only.

Adenoscan should be given as a continuous peripheral intravenous infusion.

The recommended intravenous dose for adults is 140 mcg/kg/min infused for six minutes (total dose of 0.84 mg/kg).

The required dose of thallium-201 should be injected at the midpoint of the Adenoscan infusion (i.e., after the first three minutes of Adenoscan). Thallium-201 is physically compatible with Adenoscan and may be injected directly into the Adenoscan infusion set.

The injection should be as close to the venous access as possible to prevent an inadvertent increase in the dose of Adenoscan (the contents of the IV tubing) being administered.

There are no data on the safety or efficacy of alternative Adenoscan infusion protocols.

The safety and efficacy of Adenoscan administered by the intracoronary route have not been established.

The following Adenoscan infusion nomogram may be used to determine the appropriate infusion rate corrected for total body weight:

Patient WeightInfusion Rate
kg lbs mL/min
45992.1
501102.3
551212.6
601322.8
651433.0
701543.3
751653.5
801763.8
851874.0
901984.2

This nomogram was derived from the following general formula:

Note: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration.

How Supplied

Adenoscan (adenosine injection) is supplied as 20 mL and 30 mL vials of sterile, nonpyrogenic solution in normal saline.

NDC 0469-0871-20Product Code 87120

60 mg/20 mL (3 mg/mL) in a 20 mL single-dose, flip-top glass vial, packaged individually and in packages of ten.

NDC 0469-0871-30Product Code 87130

90 mg/30 mL (3 mg/mL) in a 30 mL single-dose, flip-top glass vial, packaged individually and in packages of ten.

Store at controlled room temperature 15°-30°C (59°-86°F)

Do not refrigerate as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use.

Contains no preservative. Discard unused portion.

Rx only

Marketed by:

Astellas Pharma US, Inc.
Deerfield, IL 60015-2548

Manufactured by:

Hospira, Inc.

Lake Forest, IL 60045 USA

July 2005

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014